MEDALIST Trial: The Need for Blood Transfusions Was Reduced in Myelodysplastic Syndrome Patients

Dr. Pierre Fenaux, of Hôpital Saint Louis, Paris and lead author of the MEDALIST trial, told Ash Clinical News that treatment with the investigational drug, luspatercept, improved the rate of…

Continue Reading MEDALIST Trial: The Need for Blood Transfusions Was Reduced in Myelodysplastic Syndrome Patients